跳至主要内容
临床试验/ISRCTN14688109
ISRCTN14688109招募中不适用

Investigation of the potential beneficial effects of cannabidiol in the management of oral-lingual-buccal dyskinesias using animal studies and a clinical trial

Stellenbosch University0 个研究点目标入组 60 人开始时间: 2015年5月7日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Adults 18 years and older
  • 2. Currently meets the ICD-10 diagnosis of a psychotic disorder, verified with the Mini International Neuropsychiatric Interview (MINI-PLUS) questionnaire.
  • 3. Currently meets the clinical diagnosis of tardive dyskinesia confirmed with the Abnormal Involuntary Movement Scale (AIMS)
  • 4. Patients should currently be receiving treatment for a psychotic disorder and should be on either the atypical or conventional antipsychotics
  • 5. Patient gives informed consent

排除标准

  • 1. ICD-10 diagnosis of an organic mental illness, substance misuse disorder or a seizure disorder
  • 2. Serious or chronic physical illness
  • 3. Known severe drug allergies or hypersensitivity to CBD

研究者

相似试验